Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Neoplasm Metastasis × Capecitabine × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Interventional 121 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Conditions

Solid Tumors 1 Neoplasm Metastasis 1 HER2-positive Breast Cancer 1 Breast Neoplasms 1

Interventions

tempol 1 talazoparib 1 selitrectinib 1 adagrasib 1 Lapatinib 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00338247 2016-04-06

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Novartis

Approved for marketing

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡